With the national rollout of the COVID-19 vaccine already underway, healthcare facilities nationwide are being faced with the challenge of balancing safety, documentation, and efficiency, in their protocols for vaccine distribution.
Since our foundation, ConsortiEX has aimed to deliver highly innovative IT systems for hospitals and their affiliated networks. A crucial part of that goal was a seamlessly integrated solution that would satisfy the need for both anticipatory batch and patient specific compounding. We have achieved this with our[...]
The FDA released a finalized questions and answers guidance on data integrity compliance. The FDA guidance adheres to requirements under current good manufacturing practice ( cGMP) for drugs and biologics.
The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)
At ConsortiEX, we work diligently to create solutions designed specifically for the unique needs of health system pharmacies. The result is our Assure-Trak® IV Workflow Management Dynamic Patient Specific Compounding application a dynamically configurable IV Workflow solution to enhance patient safety and optimize[...]
ConsortiEX is proudly attending ASHP Midyear. Stop by Booth 900 to see how our intuitive Pharmacy-Focused ERP solutions can enhance your patient safety, ensure quality control, and simplify compliance, first-hand and in-person. Our new InsightRX Passive Audit Monitoring hood will be on display.
Introducing InsightRX Passive Audit Monitoring: See what others miss.
We want to thank everybody who came to visit our booth at this year’s ASHP Summer Meetings & Exhibition.
We recently sat down with ConsortiEX CEO, Neal Long, to discuss the company’s background and learn more about its plans to help hospitals safely distribute, source and track compounded pharmaceuticals among affiliated hospitals. addresses the worldwide problem of drug availability, patient safety and high costs. The[...]